Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_52310 | 100 | 2.08 | Mlig455_014082 | Neo: - Age: - Region-enriched R2: 4.038/0.02037 |
Mlig455_014082 {REF} {Length: 1503} {Smed: dd_Smed_v6_12908_0_1, dd_Smed_v6_12908_0_1, [Score=52.4, Expect=1e-08]} {RNA1509_50808} {RNA1310_3413} {RNA815_20403} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -4.458 | 1.978 | 1.00000 | 1.00000 | |
RegionR2 | 4.038 | 1.978 | 0.00091 | 0.02037 | |
RegionR3 | 1.871 | 1.978 | 0.12062 | 0.60001 | |
RegionR4 | -0.951 | 1.978 | 0.92722 | 1.00000 | |
RegionR5 | -1.073 | 1.978 | 0.94717 | 1.00000 | |
RegionR6 | 1.482 | 1.978 | 0.23709 | 0.82042 | |
RegionR7 | 2.568 | 1.978 | 0.06011 | 0.46984 | |
RegionR8 | -3.478 | 1.978 | 1.00000 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.182 | 1.978 | 0.99996 | 1.00000 | |
RegenerationR2 | -0.721 | 1.978 | 0.24710 | 0.69459 | |
RegenerationR3 | -0.732 | 1.978 | 0.41447 | 0.81157 | |
RegenerationR4 | 1.27 | 1.978 | 0.20766 | 0.65471 | |
RegenerationR5 | 1.188 | 1.978 | 0.24001 | 0.67373 | |
RegenerationR6 | 0.282 | 1.978 | 0.75757 | 0.95597 | |
RegenerationBL | 1.659 | 1.978 | 0.29680 | 0.65953 | |
RegenerationTP | 1.707 | 1.978 | 0.43202 | 0.85467 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_52310 | 100 | 2.08 | Mlig455_014082 | Neo: - Age: - Region-enriched R2: 4.038/0.02037 |
5 | - | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_014082 {REF} {Length: 1503} {Smed: dd_Smed_v6_12908_0_1, dd_Smed_v6_12908_0_1, [Score=52.4, Expect=1e-08]} {RNA1509_50808} {RNA1310_3413} {RNA815_20403} | |
2. | MligTC455_42785 | 79 | 1.65 | Mlig455_004724 | Neo: - Age: Down-Up-Down |
3.553 | - | 0.865 | 0.924 | 0.790 | 0.974 | - | Mlig455_004724 {REF} {Length: 1460} {NoTransDecoderORF} {RNA1509_29447} {RNA1310_33893.1, RNA1509_29447} {RNA1509_29447, RNA815_16689.1} | |
3. | MligTC455_48428 | 578 | 12.04 | Mlig455_034987, Mlig455_053697, Mlig455_064889 | Neo: - Age: - |
NEO1 | 3.343 | - | 0.734 | 0.854 | 0.789 | 0.966 | - | Mlig455_034987 {REF} {Length: 1449} {Pfam: Immunoglobulin domain [PF13927.8, score=83.0]; Immunoglobulin I-set domain [PF07679.18, score=69.9]; Immunoglobulin domain [PF13895.8, score=59.6]; Immunoglobulin domain [PF00047.27, score=52.1]; Immunoglobulin V-set domain [PF07686.19, score=43.6]; Immunoglobulin domain [PF18452.3, score=26.9]} {Human: ENSG00000067141, NEO1, neogenin 1, [Score=102, Expect=1e-22]; ENSG00000166450, PRTG, protogenin, [Score=97.8, Expect=3e-21]} {Mouse: ENSMUSG00000036030, Prtg, protogenin, [Score=94.4, Expect=3e-20]} {Dmel: FBgn0011592, fra, frazzled, [Score=76.6, Expect=1e-14]} {Celegans: WBGene00004256, pxn-1, Peroxidasin homolog, [Score=51.6, Expect=9e-07]} {Smed: dd_Smed_v6_11123_0_1, dd_Smed_v6_11123_0_1, [Score=59.7, Expect=2e-09]} {RNA1509_18708} {RNA1310_41845} {RNA815_22774} Mlig455_053697 {REF} {Length: 5168} {Pfam: Fibronectin type III domain [PF00041.23, score=164.7]; Immunoglobulin domain [PF13927.8, score=111.6]; Immunoglobulin I-set domain [PF07679.18, score=105.0]; Immunoglobulin domain [PF13895.8, score=85.3]; Immunoglobulin domain [PF00047.27, score=61.8]; Immunoglobulin V-set domain [PF07686.19, score=50.1]; Purple acid Phosphatase, N-terminal domain [PF16656.7, score=41.7]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=26.3]; Immunoglobulin domain [PF18452.3, score=25.2]} {Human: ENSG00000067141, NEO1, neogenin 1, [RH, Score=313, Expect=1e-86]} {Mouse: ENSMUSG00000032340, Neo1, neogenin, [RH, Score=298, Expect=8e-82]} {Dmel: FBgn0011592, fra, frazzled, [RH, Score=242, Expect=2e-64]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=82.8, Expect=2e-15]} {Smed: dd_Smed_v6_11409_0_1, dd_Smed_v6_11409_0_1, [RH, Score=114, Expect=2e-25]} {RNA1509_18708} {RNA1310_6185.1} {RNA815_22774} Mlig455_064889 {REF} {Length: 4838} {Pfam: Fibronectin type III domain [PF00041.23, score=167.9]; Immunoglobulin domain [PF13927.8, score=111.8]; Immunoglobulin I-set domain [PF07679.18, score=105.5]; Immunoglobulin domain [PF13895.8, score=85.9]; Immunoglobulin domain [PF00047.27, score=60.6]; Immunoglobulin V-set domain [PF07686.19, score=50.4]; Purple acid Phosphatase, N-terminal domain [PF16656.7, score=42.6]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=26.5]; Immunoglobulin domain [PF18452.3, score=25.3]; Neuron-derived neurotrophic factor [PF10179.11, score=20.3]} {Human: ENSG00000067141, NEO1, neogenin 1, [RH, Score=311, Expect=5e-86]} {Mouse: ENSMUSG00000032340, Neo1, neogenin, [RH, Score=300, Expect=2e-82]} {Dmel: FBgn0011592, fra, frazzled, [RH, Score=239, Expect=1e-63]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=81.6, Expect=4e-15]} {Smed: dd_Smed_v6_7195_0_1, dd_Smed_v6_7195_0_1, [Score=111, Expect=2e-24]} {RNA1509_18708} {RNA1310_6185.1} {RNA815_22774} |
4. | MligTC455_18897 | 296 | 6.16 | Mlig455_013372 | Neo: - Age: - Region-enriched R2: 3.633/0.00016 |
RGS20 | 3.159 | - | 0.764 | 0.718 | 0.723 | 0.954 | - | Mlig455_013372 {REF} {Length: 1310} {TRANSSPLICED} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=122.1]} {Human: ENSG00000147509, RGS20, regulator of G protein signaling 20, [RH, Score=201, Expect=2e-65]; ENSG00000091844, RGS17, regulator of G protein signaling 17, [RH, Score=196, Expect=5e-64]; ENSG00000171700, RGS19, regulator of G protein signaling 19, [RH, Score=194, Expect=3e-63]} {Mouse: ENSMUSG00000002459, Rgs20, regulator of G-protein signaling 20, [RH, Score=199, Expect=5e-65]; ENSMUSG00000019775, Rgs17, regulator of G-protein signaling 17, [RH, Score=198, Expect=8e-65]} {Dmel: FBgn0028743, Dhit, Double hit, [RH, Score=213, Expect=7e-70]} {Celegans: WBGene00004345, rgs-2, Regulator of G-protein signaling rgs-2, [RH, Score=173, Expect=9e-56]} {Smed: dd_Smed_v6_8877_0_1, dd_Smed_v6_8877_0_1, [RH, Score=187, Expect=4e-58]} {RNA1509_49447} {RNA1310_26662, RNA1509_49447} {RNA1509_49447, RNA815_5788} |
5. | MligTC455_46982 | 256 | 5.34 | Mlig455_044826 | Neo: - Age: - |
SYN3 | 2.658 | - | - | 0.819 | 0.876 | 0.963 | - | Mlig455_044826 {REF} {Length: 2562} {TRANSSPLICED} {Pfam: Synapsin, ATP binding domain [PF02750.16, score=168.9]} {Human: ENSG00000185666, SYN3, synapsin III, [RH, Score=176, Expect=7e-53]} {Mouse: ENSMUSG00000059602, Syn3, synapsin III, [Score=173, Expect=2e-49]; ENSMUSG00000037217, Syn1, synapsin I, [Score=170, Expect=6e-48]} {Dmel: FBgn0004575, Syn, Synapsin, [Score=186, Expect=1e-54]} {Celegans: WBGene00004913, snn-1, SyNapsiN; Synapsin, [Score=105, Expect=6e-26]} {Smed: dd_Smed_v6_3135_0_2, dd_Smed_v6_3135_0_2, [RH, Score=216, Expect=3e-68]} {RNA1310_32498} {RNA815_34432} |
6. | MligTC455_32612 | 55 | 1.15 | Mlig455_015630 | Neo: - Age: - Region-enriched R2: 5.626/0.02523 |
ARX | 2.586 | - | - | 0.848 | 0.783 | 0.955 | - | Mlig455_015630 {REF} {Length: 2012} {Pfam: Homeodomain [PF00046.31, score=83.5]} {Human: ENSG00000004848, ARX, aristaless related homeobox, [RH, Score=134, Expect=1e-34]} {Mouse: ENSMUSG00000035277, Arx, aristaless related homeobox, [RH, Score=133, Expect=1e-34]} {Dmel: FBgn0000061, al, aristaless, [RH, Score=130, Expect=3e-34]} {Celegans: WBGene00044330, alr-1, AristaLess (Drosophila homeodomain) Related, [RH, Score=118, Expect=2e-30]} {Smed: dd_Smed_v6_63359_0_1, dd_Smed_v6_63359_0_1, [Score=119, Expect=3e-33]} {RNA1310_42333.1} {RNA815_48205} |
7. | MligTC455_12685 | 123 | 2.56 | Mlig455_016759 | Neo: - Age: - |
CACNA1C | 2.568 | - | - | 0.832 | 0.754 | 0.982 | - | Mlig455_016759 {REF} {Length: 8335} {Pfam: Ion transport protein [PF00520.33, score=554.7]; Voltage gated calcium channel IQ domain [PF08763.13, score=101.9]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=91.1]; Polycystin cation channel [PF08016.14, score=22.2]} {Human: ENSG00000151067, CACNA1C, calcium voltage-gated channel subunit alpha1 C, [Score=1386, Expect=0.0]; ENSG00000285479, CACNA1C, calcium voltage-gated channel subunit alpha1 C, [Score=1386, Expect=0.0]; ENSG00000157388, CACNA1D, calcium voltage-gated channel subunit alpha1 D, [Score=1350, Expect=0.0]; ENSG00000081248, CACNA1S, calcium voltage-gated channel subunit alpha1 S, [Score=1324, Expect=0.0]} {Mouse: ENSMUSG00000051331, Cacna1c, calcium channel, voltage-dependent, L type, alpha 1C subunit, [Score=1393, Expect=0.0]; ENSMUSG00000015968, Cacna1d, calcium channel, voltage-dependent, L type, alpha 1D subunit, [Score=1343, Expect=0.0]} {Dmel: FBgn0001991, Ca-alpha1D, Ca[2+]-channel protein alpha[[1]] subunit D, [Score=1474, Expect=0.0]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=1386, Expect=0.0]} {Smed: dd_Smed_v6_8899_0_23, dd_Smed_v6_8899_0_23, [Score=1537, Expect=0.0]} {RNA1509_7565} {RNA1310_601} {RNA815_3074} |
8. | MligTC455_02931 | 215 | 4.47 | Mlig455_007216, Mlig455_007226, Mlig455_007449 | Neo: - Age: - |
DACH1 | 2.518 | - | 0.786 | 0.780 | - | 0.952 | - | Mlig455_007216 {REF} {Length: 1825} {Pfam: SKI/SNO/DAC family [PF02437.19, score=116.5]} {Human: ENSG00000276644, DACH1, dachshund family transcription factor 1, [RH, Score=213, Expect=6e-60]} {Mouse: ENSMUSG00000055639, Dach1, dachshund family transcription factor 1, [RH, Score=213, Expect=5e-60]} {Dmel: FBgn0005677, dac, dachshund, [RH, Score=193, Expect=5e-52]} {Celegans: WBGene00000895, dac-1, DAChsund transcription factor homolog, [RH, Score=164, Expect=1e-44]} {Smed: dd_Smed_v6_14598_0_1, dd_Smed_v6_14598_0_1, [RH, Score=237, Expect=9e-71]} {RNA1310_26896.1} {RNA815_36501} Mlig455_007226 {REF} {Length: 2460} {Pfam: SKI/SNO/DAC family [PF02437.19, score=117.2]} {Human: ENSG00000276644, DACH1, dachshund family transcription factor 1, [RH, Score=213, Expect=9e-62]} {Mouse: ENSMUSG00000055639, Dach1, dachshund family transcription factor 1, [RH, Score=212, Expect=7e-62]} {Dmel: FBgn0005677, dac, dachshund, [RH, Score=191, Expect=2e-53]} {Celegans: WBGene00000895, dac-1, DAChsund transcription factor homolog, [RH, Score=163, Expect=7e-46]} {Smed: dd_Smed_v6_14598_0_1, dd_Smed_v6_14598_0_1, [RH, Score=236, Expect=1e-72]} {RNA1310_26896.1} {RNA815_23939} Mlig455_007449 {REF} {Length: 2275} {Pfam: SKI/SNO/DAC family [PF02437.19, score=116.6]} {Human: ENSG00000276644, DACH1, dachshund family transcription factor 1, [RH, Score=213, Expect=1e-59]} {Mouse: ENSMUSG00000055639, Dach1, dachshund family transcription factor 1, [RH, Score=212, Expect=6e-60]} {Dmel: FBgn0005677, dac, dachshund, [RH, Score=192, Expect=8e-52]} {Celegans: WBGene00000895, dac-1, DAChsund transcription factor homolog, [RH, Score=163, Expect=1e-44]} {Smed: dd_Smed_v6_14598_0_1, dd_Smed_v6_14598_0_1, [RH, Score=236, Expect=2e-70]} {RNA1310_26896.1} {RNA815_23939} |
9. | MligTC455_45202 | 245 | 5.09 | Mlig455_024626 | Neo: - Age: Up-Down-Up |
DLG5 | 2.517 | - | 0.706 | 0.836 | - | 0.975 | - | Mlig455_024626 {REF} {Length: 7074} {Pfam: PDZ domain [PF00595.26, score=126.1]; PDZ domain [PF17820.3, score=97.9]; PDZ domain [PF13180.8, score=52.9]} {Human: ENSG00000151208, DLG5, discs large MAGUK scaffold protein 5, [RH, Score=213, Expect=3e-56]; ENSG00000274429, DLG5, discs large MAGUK scaffold protein 5, [RH, Score=213, Expect=3e-56]} {Mouse: ENSMUSG00000021782, Dlg5, discs large MAGUK scaffold protein 5, [RH, Score=204, Expect=2e-52]} {Dmel: FBgn0032363, Dlg5, Discs large 5, [Score=147, Expect=3e-35]} {Celegans: WBGene00013683, zoo-1, ZO-1 (Zonula Occludens tight junctional protein) Ortholog, [Score=65.5, Expect=3e-10]} {RNA1509_10377} {RNA1310_678} {RNA815_15135} |
10. | MligTC455_41448 | 192 | 4.01 | Mlig455_066626 | Neo: - Age: - Region-specific R2: 6.449 Region-enriched R2: 4.988/0.02499 |
2.489 | - | 0.780 | 0.743 | - | 0.966 | - | Mlig455_066626 {REF} {Length: 987} {Pfam: F5/8 type C domain [PF00754.27, score=25.0]} {Smed: dd_Smed_v6_83746_0_1, dd_Smed_v6_83746_0_1, [Score=52.4, Expect=8e-09]} {RNA1509_36923} {RNA1310_37535} {RNA815_20943} | |
11. | MligTC455_15467 | 225 | 4.69 | Mlig455_000546 | Neo: - Age: Down-Up-Up Region-specific R2: 6.857 Region-enriched R2: 5.997/0.00105 |
2.481 | - | 0.763 | - | 0.767 | 0.951 | - | Mlig455_000546 {REF} {Length: 844} {Pfam: Pancreatic hormone peptide [PF00159.20, score=42.9]} {Smed: dd_Smed_v6_16946_0_1, dd_Smed_v6_16946_0_1, [Score=39.7, Expect=1e-05]} {RNA1310_53697} {RNA815_26198} | |
12. | MligTC455_27918 | 42 | 0.87 | Mlig455_004025, Mlig455_004105, Mlig455_039294 | Neo: - Age: Down-Up-Up |
2.469 | - | - | 0.805 | - | 0.951 | 0.713 | Mlig455_004025 {REF} {Length: 2650} {RNA1310_16141} {RNA815_7007} Mlig455_004105 {REF} {Length: 1268} {RNA1310_85247} {RNA815_59251} Mlig455_039294 {REF} {Length: 2639} {RNA1310_16141} {RNA815_7007} |
|
13. | MligTC455_54106 | 87 | 1.81 | Mlig455_046338, Mlig455_068234 | Neo: Int S/G2/M Age: Up-Down-Down |
PLCB1, PLCB3 | 2.467 | - | - | 0.750 | - | 0.962 | 0.755 | Mlig455_046338 {REF} {Length: 4577} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=201.8]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=127.9]; PH domain [PF17787.3, score=69.3]; Protein of unknown function (DUF1154) [PF06631.13, score=28.5]; Phosphoinositide-specific phospholipase C, efhand-like [PF09279.13, score=27.5]} {Human: ENSG00000182621, PLCB1, phospholipase C beta 1, [Score=797, Expect=0.0]; ENSG00000149782, PLCB3, phospholipase C beta 3, [Score=796, Expect=0.0]} {Mouse: ENSMUSG00000051177, Plcb1, phospholipase C, beta 1, [Score=801, Expect=0.0]; ENSMUSG00000024960, Plcb3, phospholipase C, beta 3, [Score=784, Expect=0.0]} {Dmel: FBgn0004611, Plc21C, Phospholipase C at 21C, [Score=418, Expect=4e-125]} {Celegans: WBGene00001177, egl-8, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta egl-8, [Score=671, Expect=0.0]} {Smed: dd_Smed_v6_3221_0_1, dd_Smed_v6_3221_0_1, [Score=702, Expect=0.0]} {RNA1509_50989} {RNA1310_17477} {RNA815_25811} Mlig455_068234 {REF} {Length: 4646} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=201.7]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=127.9]; PH domain [PF17787.3, score=123.2]; Protein of unknown function (DUF1154) [PF06631.13, score=28.5]; Phosphoinositide-specific phospholipase C, efhand-like [PF09279.13, score=27.4]} {Human: ENSG00000149782, PLCB3, phospholipase C beta 3, [RH, Score=837, Expect=0.0]; ENSG00000182621, PLCB1, phospholipase C beta 1, [RH, Score=831, Expect=0.0]} {Mouse: ENSMUSG00000051177, Plcb1, phospholipase C, beta 1, [RH, Score=830, Expect=0.0]; ENSMUSG00000024960, Plcb3, phospholipase C, beta 3, [RH, Score=827, Expect=0.0]} {Dmel: FBgn0004611, Plc21C, Phospholipase C at 21C, [Score=444, Expect=7e-134]} {Celegans: WBGene00001177, egl-8, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta egl-8, [Score=684, Expect=0.0]} {Smed: dd_Smed_v6_3221_0_2, dd_Smed_v6_3221_0_2, [Score=716, Expect=0.0]} {RNA1509_50989} {RNA1310_17477, RNA1509_50989} {RNA1509_50989, RNA815_25811} |
14. | MligTC455_03731 | 113 | 2.35 | Mlig455_066791 | Neo: - Age: - |
2.453 | - | 0.781 | 0.714 | - | 0.958 | - | Mlig455_066791 {REF} {Length: 1679} {Smed: dd_Smed_v6_13648_0_1, dd_Smed_v6_13648_0_1, [RH, Score=79.7, Expect=2e-16]} {RNA1509_58026} {RNA1310_23180, RNA1509_58026} {RNA1509_58026, RNA815_34008} | |
15. | MligTC455_49863 | 62 | 1.29 | Mlig455_019320, Mlig455_019542 | Neo: - Age: - |
SHOX2 | 2.44 | - | 0.719 | 0.768 | - | 0.953 | - | Mlig455_019320 {REF} {Length: 1251} {Pfam: Homeodomain [PF00046.31, score=83.4]; Homeobox KN domain [PF05920.13, score=23.0]} {Human: ENSG00000168779, SHOX2, short stature homeobox 2, [Score=88.2, Expect=5e-21]; ENSG00000185960, SHOX, short stature homeobox, [Score=86.3, Expect=7e-20]} {Mouse: ENSMUSG00000027833, Shox2, short stature homeobox 2, [Score=88.2, Expect=3e-21]} {Dmel: FBgn0085396, CG34367, [Score=89.4, Expect=7e-21]} {Celegans: WBGene00006744, unc-4, Homeobox protein unc-4, [Score=84.0, Expect=2e-19]} {Smed: dd_Smed_v6_22163_0_1, dd_Smed_v6_22163_0_1, [Score=87.0, Expect=8e-20]} {RNA1310_51707} {RNA815_41055} Mlig455_019542 {REF} {Length: 1249} {Pfam: Homeodomain [PF00046.31, score=83.4]; Homeobox KN domain [PF05920.13, score=23.0]} {Human: ENSG00000168779, SHOX2, short stature homeobox 2, [Score=88.6, Expect=4e-21]; ENSG00000185960, SHOX, short stature homeobox, [Score=86.3, Expect=6e-20]} {Mouse: ENSMUSG00000027833, Shox2, short stature homeobox 2, [Score=88.6, Expect=3e-21]} {Dmel: FBgn0085396, CG34367, [Score=89.4, Expect=7e-21]} {Celegans: WBGene00006744, unc-4, Homeobox protein unc-4, [Score=86.7, Expect=3e-20]} {Smed: dd_Smed_v6_22163_0_1, dd_Smed_v6_22163_0_1, [Score=87.0, Expect=8e-20]} {RNA1310_51707} {RNA815_41055} |
16. | MligTC455_20350 | 434 | 9.05 | Mlig455_002780, Mlig455_066934 | Neo: - Age: - Region-enriched R2: 3.513/0.00619 |
SYT12 | 2.429 | - | 0.731 | 0.715 | - | 0.983 | - | Mlig455_002780 {REF} {Length: 2380} {Pfam: C2 domain [PF00168.32, score=69.7]} {Human: ENSG00000173227, SYT12, synaptotagmin 12, [Score=214, Expect=3e-64]} {Mouse: ENSMUSG00000049303, Syt12, synaptotagmin XII, [Score=207, Expect=1e-61]} {Dmel: FBgn0261085, Syt12, Synaptotagmin 12, [Score=182, Expect=3e-50]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=142, Expect=2e-37]} {Smed: dd_Smed_v6_8032_0_1, dd_Smed_v6_8032_0_1, [Score=234, Expect=3e-72]} {RNA1310_10982.1} {RNA815_10652.1} Mlig455_066934 {REF} {Length: 2274} {Pfam: C2 domain [PF00168.32, score=69.7]} {Human: ENSG00000173227, SYT12, synaptotagmin 12, [Score=214, Expect=3e-64]} {Mouse: ENSMUSG00000049303, Syt12, synaptotagmin XII, [Score=206, Expect=1e-61]} {Dmel: FBgn0261085, Syt12, Synaptotagmin 12, [Score=182, Expect=3e-50]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=142, Expect=2e-37]} {Smed: dd_Smed_v6_8032_0_1, dd_Smed_v6_8032_0_1, [Score=234, Expect=2e-72]} {RNA1310_10982.1} {RNA815_10652.1} |
17. | MligTC455_37440 | 78 | 1.62 | Mlig455_019008 | Neo: - Age: - |
1.889 | - | - | - | - | 0.928 | 0.961 | Mlig455_019008 {REF} {Length: 1896} {RNA1509_49181} {RNA1310_31711} {RNA815_17406} | |
18. | MligTC455_17253 | 49 | 1.03 | Mlig455_019947 | Neo: - Age: - Region-enriched R2: 5.637/0.04654 |
1.85 | - | 0.861 | - | - | 0.989 | - | Mlig455_019947 {REF} {Length: 2249} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=23.5]} {Smed: dd_Smed_v6_42201_0_1, dd_Smed_v6_42201_0_1, [RH, Score=148, Expect=3e-40]} {RNA1310_19413.1} {RNA815_30978} | |
19. | MligTC455_38197 | 294 | 6.13 | Mlig455_029736 | Neo: - Age: - Region-enriched R7: 3.140/0.02454 |
PHACTR4 | 1.799 | - | 0.829 | - | - | 0.970 | - | Mlig455_029736 {REF} {Length: 2702} {Pfam: RPEL repeat [PF02755.17, score=55.4]} {Human: ENSG00000204138, PHACTR4, phosphatase and actin regulator 4, [Score=172, Expect=8e-46]; ENSG00000112419, PHACTR2, phosphatase and actin regulator 2, [Score=170, Expect=2e-45]} {Mouse: ENSMUSG00000062866, Phactr2, phosphatase and actin regulator 2, [Score=172, Expect=9e-47]; ENSMUSG00000066043, Phactr4, phosphatase and actin regulator 4, [Score=164, Expect=3e-43]} {Dmel: FBgn0052264, CG32264, [Score=159, Expect=2e-42]} {Celegans: WBGene00009174, F26H9.2, [Score=155, Expect=3e-41]} {Smed: dd_Smed_v6_5826_0_1, dd_Smed_v6_5826_0_1, [Score=168, Expect=1e-45]} {RNA1509_37565} {RNA1310_4856.1} {RNA815_7774} |
20. | MligTC455_37467 | 2117 | 44.11 | Mlig455_056425 | Neo: - Age: - |
PAM | 1.796 | - | - | - | 0.828 | 0.968 | - | Mlig455_056425 {REF} {Length: 3268} {TRANSSPLICED} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=105.0]; Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=74.8]; NHL repeat [PF01436.23, score=51.2]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [RH, Score=385, Expect=1e-120]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [RH, Score=384, Expect=1e-120]} {Dmel: FBgn0283510, Pal1, Peptidyl-alpha-hydroxyglycine-alpha-amidating lyase 1, [RH, Score=206, Expect=1e-57]} {Celegans: WBGene00020556, pamn-1, Probable peptidyl-glycine alpha-amidating monooxygenase pamn-1 Probable peptidylglycine alpha-hydroxylating monooxygenase Probable peptidyl-alpha-hydroxyglycine alpha-amidating lyase, [RH, Score=265, Expect=4e-78]} {Smed: dd_Smed_v6_4863_0_1, dd_Smed_v6_4863_0_1, [RH, Score=440, Expect=2e-143]} {RNA1509_2584, RNA1509_37968} {RNA1310_4420.1, RNA1509_2584, RNA1509_37968} {RNA1509_2584, RNA1509_37968, RNA815_4219} |
21. | MligTC455_33772 | 104 | 2.17 | Mlig455_016493 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.862/0.00025 |
1.779 | - | - | 0.813 | - | 0.966 | - | Mlig455_016493 {REF} {Length: 883} {RNA1310_43848} {RNA815_55624} | |
22. | MligTC455_00245 | 15 | 0.32 | Mlig455_040042 | Neo: - Age: - |
GPR17 | 1.778 | - | - | 0.808 | - | 0.970 | - | Mlig455_040042 {REF} {Length: 1332} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=36.0]} {Human: ENSG00000144230, GPR17, G protein-coupled receptor 17, [Score=48.9, Expect=6e-06]} {Smed: dd_Smed_v6_61185_0_1, dd_Smed_v6_61185_0_1, [Score=70.9, Expect=1e-14]} {RNA1310_142905} |
23. | MligTC455_50627 | 260 | 5.41 | Mlig455_016566, Mlig455_016617 | Neo: - Age: - Region-enriched R2: 2.464/0.02538 |
1.775 | - | - | 0.822 | - | 0.953 | - | Mlig455_016566 {REF} {Length: 1108} {Pfam: Universal stress protein family [PF00582.28, score=89.8]} {Smed: dd_Smed_v6_402_1_1, dd_Smed_v6_402_1_1, [Score=110, Expect=1e-30]} {RNA1310_31742} {RNA815_15537} Mlig455_016617 {REF} {Length: 1220} {Pfam: Universal stress protein family [PF00582.28, score=89.9]} {Smed: dd_Smed_v6_402_1_1, dd_Smed_v6_402_1_1, [Score=110, Expect=1e-30]} {RNA1310_31742} {RNA815_15537} |
|
24. | MligTC455_46725 | 1277 | 26.6 | Mlig455_002797, Mlig455_002811 | Neo: - Age: - Region-enriched R7: 2.089/0.02985 |
TMPRSS4 | 1.773 | - | - | 0.806 | - | 0.967 | - | Mlig455_002797 {REF} {Length: 1278} {Pfam: Trypsin [PF00089.28, score=217.0]; Trypsin-like peptidase domain [PF13365.8, score=29.1]} {Human: ENSG00000137648, TMPRSS4, transmembrane serine protease 4, [RH, Score=177, Expect=8e-53]} {Mouse: ENSMUSG00000032091, Tmprss4, transmembrane protease, serine 4, [RH, Score=171, Expect=5e-49]} {Dmel: FBgn0035501, CG1299, [RH, Score=160, Expect=2e-44]} {Celegans: WBGene00006619, try-1, TRYpsin-like protease, [Score=127, Expect=3e-34]} {Smed: dd_Smed_v6_2492_0_1, dd_Smed_v6_2492_0_1, [RH, Score=283, Expect=4e-94]} {RNA1509_14801} {RNA1310_24334.1} {RNA815_10378} Mlig455_002811 {REF} {Length: 1406} {Pfam: Trypsin [PF00089.28, score=216.7]; Trypsin-like peptidase domain [PF13365.8, score=29.0]} {Human: ENSG00000137648, TMPRSS4, transmembrane serine protease 4, [RH, Score=176, Expect=1e-52]} {Mouse: ENSMUSG00000032091, Tmprss4, transmembrane protease, serine 4, [RH, Score=171, Expect=3e-49]; ENSMUSG00000033825, Tpsb2, tryptase beta 2, [RH, Score=163, Expect=9e-48]} {Dmel: FBgn0035501, CG1299, [RH, Score=160, Expect=2e-44]} {Celegans: WBGene00006619, try-1, TRYpsin-like protease, [Score=127, Expect=3e-34]} {Smed: dd_Smed_v6_2492_0_1, dd_Smed_v6_2492_0_1, [RH, Score=285, Expect=7e-95]} {RNA1509_14801} {RNA1310_24334.1, RNA1509_14801} {RNA1509_14801, RNA815_10378} |
25. | MligTC455_48128 | 18 | 0.37 | Mlig455_052326 | Neo: - Age: - |
1.767 | - | - | - | 0.814 | 0.953 | - | Mlig455_052326 {REF} {Length: 3582} {RNA1310_42908} {RNA815_22744} | |
26. | MligTC455_18955 | 13 | 0.27 | Mlig455_047126 | Neo: - Age: - |
1.766 | - | - | 0.812 | - | 0.954 | - | Mlig455_047126 {REF} {Length: 1058} | |
27. | MligTC455_29261 | 34 | 0.71 | Mlig455_024258 | Neo: - Age: - |
1.765 | - | - | 0.812 | - | 0.953 | - | Mlig455_024258 {REF} {Length: 1171} {RNA1509_25125} {RNA1310_234.1} {RNA815_23.1} | |
28. | MligTC455_19616 | 70 | 1.46 | Mlig455_045100 | Neo: - Age: - |
RPH3A | 1.761 | - | 0.793 | - | - | 0.968 | - | Mlig455_045100 {REF} {Length: 2276} {Pfam: C2 domain [PF00168.32, score=141.3]} {Human: ENSG00000089169, RPH3A, rabphilin 3A, [RH, Score=247, Expect=9e-73]} {Mouse: ENSMUSG00000029608, Rph3a, rabphilin 3A, [RH, Score=244, Expect=9e-72]} {Dmel: FBgn0030230, Rph, Rabphilin, [Score=179, Expect=2e-50]} {Celegans: WBGene00004316, rbf-1, Rabphilin-1, [Score=209, Expect=6e-58]} {Smed: dd_Smed_v6_12977_0_1, dd_Smed_v6_12977_0_1, [Score=216, Expect=3e-62]} {RNA1310_30378} {RNA815_36857} |
29. | MligTC455_45201 | 166 | 3.46 | Mlig455_024614 | Neo: - Age: - |
DLG5 | 1.755 | - | - | 0.781 | - | 0.974 | - | Mlig455_024614 {REF} {Length: 9018} {Pfam: PDZ domain [PF00595.26, score=124.9]; PDZ domain [PF17820.3, score=96.7]; PDZ domain [PF13180.8, score=51.9]} {Human: ENSG00000151208, DLG5, discs large MAGUK scaffold protein 5, [RH, Score=234, Expect=2e-61]; ENSG00000274429, DLG5, discs large MAGUK scaffold protein 5, [RH, Score=234, Expect=2e-61]} {Mouse: ENSMUSG00000021782, Dlg5, discs large MAGUK scaffold protein 5, [RH, Score=221, Expect=2e-57]} {Dmel: FBgn0032363, Dlg5, Discs large 5, [RH, Score=162, Expect=1e-39]} {Celegans: WBGene00013683, zoo-1, ZO-1 (Zonula Occludens tight junctional protein) Ortholog, [Score=75.5, Expect=3e-13]} {Smed: dd_Smed_v6_7374_0_1, dd_Smed_v6_7374_0_1, [Score=55.5, Expect=3e-07]} {RNA1509_10377} {RNA1310_678} {RNA815_15135} |
30. | MligTC455_44372 | 319 | 6.64 | Mlig455_016467 | Neo: - Age: - Region-enriched R2: 2.783/0.04502 |
1.753 | - | - | 0.785 | - | 0.968 | - | Mlig455_016467 {REF} {Length: 3430} {Pfam: Innexin [PF00876.20, score=423.2]} {Dmel: FBgn0027108, Inx2, Innexin 2, [Score=107, Expect=2e-25]} {Celegans: WBGene00002123, inx-1, Innexin, [Score=332, Expect=1e-110]} {Smed: dd_Smed_v6_6114_0_1, dd_Smed_v6_6114_0_1, [RH, Score=569, Expect=0.0]} {RNA1509_40288} {RNA1310_5443} {RNA815_16099} | |
31. | MligTC455_41556 | 259 | 5.39 | Mlig455_007065 | Neo: - |
FOXC2 | 1.751 | - | 0.798 | - | - | 0.953 | - | Mlig455_007065 {REF} {Length: 3394} {Pfam: Forkhead domain [PF00250.20, score=132.6]} {Human: ENSG00000176692, FOXC2, forkhead box C2, [RH, Score=214, Expect=9e-62]; ENSG00000054598, FOXC1, forkhead box C1, [RH, Score=207, Expect=1e-58]} {Mouse: ENSMUSG00000050295, Foxc1, forkhead box C1, [RH, Score=217, Expect=2e-62]; ENSMUSG00000046714, Foxc2, forkhead box C2, [RH, Score=216, Expect=2e-62]} {Dmel: FBgn0014143, croc, crocodile, [RH, Score=191, Expect=3e-53]} {Celegans: WBGene00006853, unc-130, [Score=158, Expect=5e-43]} {Smed: dd_Smed_v6_16297_0_1, dd_Smed_v6_16297_0_1, [RH, Score=213, Expect=5e-61]} {RNA1509_45187} {RNA1310_22875.1} {RNA815_10125} |
32. | MligTC455_43964 | 422 | 8.8 | Mlig455_003555, Mlig455_015506 | Neo: - Age: logFC(26M/2M)=0.500 Region-specific R2: 3.721 Region-enriched R2: 4.796/0.00000 Regeneration-downregulated R2: -1.526 Regeneration-depleted R2: -1.526 |
1.748 | - | - | 0.778 | - | 0.970 | - | Mlig455_003555 {REF} {Length: 745} {RNA1509_44220} {RNA1310_56516, RNA1509_44220} {RNA1509_44220, RNA815_28877} Mlig455_015506 {REF} {Length: 752} {RNA1509_44220} {RNA1310_56516} {RNA815_28877} |
|
33. | MligTC455_15016 | 70 | 1.45 | Mlig455_030543 | Neo: - Age: - |
LHX3 | 1.736 | - | - | 0.777 | - | 0.959 | - | Mlig455_030543 {REF} {Length: 2024} {Pfam: LIM domain [PF00412.24, score=113.8]; Homeodomain [PF00046.31, score=69.9]; Homeobox KN domain [PF05920.13, score=20.4]} {Human: ENSG00000107187, LHX3, LIM homeobox 3, [RH, Score=319, Expect=6e-106]; ENSG00000121454, LHX4, LIM homeobox 4, [RH, Score=311, Expect=1e-102]} {Mouse: ENSMUSG00000026934, Lhx3, LIM homeobox protein 3, [RH, Score=319, Expect=8e-106]; ENSMUSG00000026468, Lhx4, LIM homeobox protein 4, [RH, Score=311, Expect=6e-103]} {Dmel: FBgn0002023, Lim3, [RH, Score=323, Expect=5e-106]} {Celegans: WBGene00000438, ceh-14, Homeobox protein ceh-14, [RH, Score=267, Expect=2e-86]} {Smed: dd_Smed_v6_20755_0_1, dd_Smed_v6_20755_0_1, [RH, Score=328, Expect=3e-111]} {RNA1310_33977} {RNA815_27636} |
34. | MligTC455_24345 | 161 | 3.36 | Mlig455_001456 | Neo: - Age: - |
1.727 | - | - | - | 0.768 | 0.959 | - | Mlig455_001456 {REF} {Length: 3298} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=18.3]} {RNA1310_23364} {RNA815_42991} | |
35. | MligTC455_32502 | 47 | 0.98 | Mlig455_065385 | Neo: - Age: - |
GRIA1 | 1.727 | - | - | - | 0.750 | 0.977 | - | Mlig455_065385 {REF} {Length: 4211} {Pfam: Ligand-gated ion channel [PF00060.28, score=197.8]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=125.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=87.6]; Receptor family ligand binding region [PF01094.30, score=62.0]} {Human: ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [RH, Score=590, Expect=0.0]; ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [RH, Score=566, Expect=0.0]} {Mouse: ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [RH, Score=590, Expect=0.0]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [RH, Score=564, Expect=0.0]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [RH, Score=561, Expect=0.0]} {Dmel: FBgn0038837, CG3822, [Score=479, Expect=2e-155]} {Celegans: WBGene00001612, glr-1, Glutamate receptor 1, [RH, Score=484, Expect=3e-156]} {Smed: dd_Smed_v6_7562_0_1, dd_Smed_v6_7562_0_1, [RH, Score=707, Expect=0.0]} {RNA1509_47919} {RNA1310_3776} {RNA815_11355.1} |
36. | MligTC455_17562 | 108 | 2.25 | Mlig455_022496 | Neo: - Age: - |
NECAB3 | 1.717 | - | 0.748 | - | - | 0.969 | - | Mlig455_022496 {REF} {Length: 1499} {Pfam: EF hand [PF00036.34, score=34.0]; EF-hand domain [PF13405.8, score=33.4]; EF-hand domain pair [PF13833.8, score=29.2]; EF-hand domain pair [PF13499.8, score=28.3]; Antibiotic biosynthesis monooxygenase [PF03992.18, score=22.0]; EF hand [PF13202.8, score=21.3]} {Human: ENSG00000125967, NECAB3, N-terminal EF-hand calcium binding protein 3, [RH, Score=189, Expect=7e-57]; ENSG00000123119, NECAB1, N-terminal EF-hand calcium binding protein 1, [RH, Score=186, Expect=1e-55]} {Mouse: ENSMUSG00000040536, Necab1, N-terminal EF-hand calcium binding protein 1, [RH, Score=191, Expect=7e-58]; ENSMUSG00000027489, Necab3, N-terminal EF-hand calcium binding protein 3, [RH, Score=191, Expect=9e-58]} {RNA1509_46831} {RNA1310_24461} {RNA815_25216} |
37. | MligTC455_29318 | 93 | 1.93 | Mlig455_068579 | Neo: - Age: logFC(26M/2M)=-0.605 |
SLC18A3 | 1.715 | - | - | 0.761 | - | 0.954 | - | Mlig455_068579 {REF} {Length: 3048} {Pfam: Major Facilitator Superfamily [PF07690.18, score=131.7]; LacY proton/sugar symporter [PF01306.21, score=23.8]; PUCC protein [PF03209.17, score=21.8]; MFS_1 like family [PF12832.9, score=19.1]; Sugar (and other) transporter [PF00083.26, score=18.5]} {Human: ENSG00000187714, SLC18A3, solute carrier family 18 member A3, [Score=393, Expect=3e-132]} {Mouse: ENSMUSG00000100241, Slc18a3, solute carrier family 18 (vesicular monoamine), member 3, [Score=395, Expect=3e-133]} {Dmel: FBgn0270928, VAChT, Vesicular acetylcholine transporter, [Score=434, Expect=6e-148]} {Celegans: WBGene00006756, unc-17, Vesicular acetylcholine transporter unc-17, [Score=392, Expect=2e-132]} {Smed: dd_Smed_v6_11630_0_1, dd_Smed_v6_11630_0_1, [Score=452, Expect=6e-156]} {RNA1509_22907} {RNA1310_5498.1} {RNA815_3951} |
38. | MligTC455_47096 | 301 | 6.27 | Mlig455_060395 | Neo: - Age: - |
SSUH2 | 1.715 | - | - | - | 0.739 | 0.976 | - | Mlig455_060395 {REF} {Length: 2019} {Pfam: DnaJ central domain [PF00684.21, score=23.3]} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=110, Expect=1e-26]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=87.4, Expect=9e-19]} {RNA1509_22065} {RNA1310_14684} {RNA815_5263.1} |
39. | MligTC455_43524 | 172 | 3.58 | Mlig455_031179 | Neo: - Age: - Region-enriched R2: 3.416/0.00534 |
SLC30A2 | 1.708 | - | 0.743 | - | - | 0.965 | - | Mlig455_031179 {REF} {Length: 2311} {Pfam: Cation efflux family [PF01545.23, score=155.3]; Dimerisation domain of Zinc Transporter [PF16916.7, score=21.1]} {Human: ENSG00000158014, SLC30A2, solute carrier family 30 member 2, [Score=350, Expect=3e-117]} {Mouse: ENSMUSG00000028836, Slc30a2, solute carrier family 30 (zinc transporter), member 2, [Score=362, Expect=3e-122]} {Dmel: FBgn0028516, ZnT35C, Zinc transporter 35C, [RH, Score=324, Expect=1e-106]} {Celegans: WBGene00011821, cdf-2, Cation Diffusion Facilitator family, [RH, Score=324, Expect=7e-108]} {Smed: dd_Smed_v6_5529_0_1, dd_Smed_v6_5529_0_1, [Score=432, Expect=4e-150]} {RNA1509_37229} {RNA1310_13324.1} {RNA815_5520} |
40. | MligTC455_48302 | 45 | 0.93 | Mlig455_056275 | Neo: - Age: - |
CHRNA7 | 1.705 | - | - | 0.750 | - | 0.955 | - | Mlig455_056275 {REF} {Length: 3506} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=176.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=131.0]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=255, Expect=4e-76]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=251, Expect=5e-75]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=250, Expect=2e-74]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=245, Expect=6e-73]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=237, Expect=7e-70]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=234, Expect=6e-69]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=271, Expect=1e-82]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=254, Expect=1e-76]} {Smed: dd_Smed_v6_18201_0_1, dd_Smed_v6_18201_0_1, [Score=471, Expect=8e-158]} {RNA1509_49660} {RNA1310_35095} {RNA815_30373} |
41. | MligTC455_04854 | 57 | 1.18 | Mlig455_032030 | Neo: - Age: - Region-enriched R2: 5.099/0.03475 |
1.704 | - | - | 0.752 | - | 0.952 | - | Mlig455_032030 {REF} {Length: 1388} {RNA1310_84273} | |
42. | MligTC455_46470 | 552 | 11.5 | Mlig455_066293 | Neo: - Age: Down-Down-Up Region-enriched R2: 3.795/0.00284 |
1.703 | - | - | 0.751 | - | 0.952 | - | Mlig455_066293 {REF} {Length: 896} {RNA1509_9692} {RNA1310_57568} {RNA815_29793} | |
43. | MligTC455_14500 | 10 | 0.21 | Mlig455_017108 | Neo: - Age: Down-Up-Up |
SSTR1 | 1.688 | - | - | 0.729 | - | 0.959 | - | Mlig455_017108 {REF} {Length: 2868} {TRANSSPLICED} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=119.2]} {Human: ENSG00000139874, SSTR1, somatostatin receptor 1, [Score=115, Expect=8e-28]} {Mouse: ENSMUSG00000035431, Sstr1, somatostatin receptor 1, [Score=116, Expect=4e-28]} {Dmel: FBgn0036789, AstC-R2, Allatostatin C receptor 2, [Score=121, Expect=2e-29]} {Celegans: WBGene00013782, npr-32, NeuroPeptide Receptor family, [RH, Score=112, Expect=2e-26]} {Smed: dd_Smed_v6_14519_0_1, dd_Smed_v6_14519_0_1, [Score=122, Expect=1e-30]} {RNA1310_55087} {RNA815_31043} |
44. | MligTC455_22212 | 1732 | 36.09 | Mlig455_009239, Mlig455_009645, Mlig455_037058 | Neo: - Age: logFC(26M/2M)=-0.722 Region-specific R2: 6.329 Region-enriched R2: 6.728/0.00000 |
LMNA | 1.684 | - | - | 0.722 | - | 0.962 | - | Mlig455_009239 {REF} {Length: 2842} {Pfam: Intermediate filament protein [PF00038.23, score=176.1]; Lamin Tail Domain [PF00932.21, score=51.0]; Myosin tail [PF01576.21, score=18.0]} {Human: ENSG00000160789, LMNA, lamin A/C, [Score=176, Expect=8e-47]} {Mouse: ENSMUSG00000028063, Lmna, lamin A, [Score=172, Expect=1e-45]} {Dmel: FBgn0002525, Lam, Lamin, [Score=189, Expect=9e-52]} {Celegans: WBGene00002050, ifa-1, Intermediate filament protein ifa-1, [RH, Score=404, Expect=6e-134]} {Smed: dd_Smed_v6_3871_0_1, dd_Smed_v6_3871_0_1, [RH, Score=563, Expect=0.0]} {RNA1509_18286} {RNA1310_9741.1} {RNA815_3167} Mlig455_009645 {REF} {Length: 2337} {Pfam: Intermediate filament protein [PF00038.23, score=176.1]; Lamin Tail Domain [PF00932.21, score=51.0]; Myosin tail [PF01576.21, score=18.0]} {Human: ENSG00000160789, LMNA, lamin A/C, [Score=176, Expect=8e-47]} {Mouse: ENSMUSG00000028063, Lmna, lamin A, [Score=172, Expect=1e-45]} {Dmel: FBgn0002525, Lam, Lamin, [Score=189, Expect=9e-52]} {Celegans: WBGene00002050, ifa-1, Intermediate filament protein ifa-1, [RH, Score=404, Expect=6e-134]} {Smed: dd_Smed_v6_3871_0_1, dd_Smed_v6_3871_0_1, [RH, Score=563, Expect=0.0]} {RNA1509_18286} {RNA1310_9741.1} {RNA815_3167} Mlig455_037058 {REF} {Length: 4944} {Pfam: Intermediate filament protein [PF00038.23, score=176.1]; Lamin Tail Domain [PF00932.21, score=51.0]; Myosin tail [PF01576.21, score=18.0]} {Human: ENSG00000160789, LMNA, lamin A/C, [Score=176, Expect=8e-47]} {Mouse: ENSMUSG00000028063, Lmna, lamin A, [Score=172, Expect=1e-45]} {Dmel: FBgn0002525, Lam, Lamin, [Score=189, Expect=9e-52]} {Celegans: WBGene00002050, ifa-1, Intermediate filament protein ifa-1, [RH, Score=404, Expect=6e-134]} {Smed: dd_Smed_v6_3871_0_1, dd_Smed_v6_3871_0_1, [RH, Score=563, Expect=0.0]} {RNA1509_18286, RNA1509_31019, RNA1509_37437} {RNA1310_9741.1, RNA1509_18286, RNA1509_31019, RNA1509_37437} {RNA1509_18286, RNA1509_31019, RNA1509_37437, RNA815_3167} |
45. | MligTC455_35000 | 20 | 0.42 | Mlig455_050562 | Neo: - Age: - |
KCNC1 | 1.68 | - | - | 0.729 | - | 0.951 | - | Mlig455_050562 {REF} {Length: 3042} {Pfam: Ion transport protein [PF00520.33, score=116.8]; BTB/POZ domain [PF02214.24, score=75.0]; Ion channel [PF07885.18, score=42.0]} {Human: ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=211, Expect=2e-60]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=209, Expect=1e-58]; ENSG00000182674, KCNB2, potassium voltage-gated channel subfamily B member 2, [Score=206, Expect=3e-56]; ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=204, Expect=3e-57]; ENSG00000158445, KCNB1, potassium voltage-gated channel subfamily B member 1, [Score=204, Expect=1e-55]; ENSG00000131398, KCNC3, potassium voltage-gated channel subfamily C member 3, [Score=203, Expect=7e-56]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=212, Expect=3e-60]; ENSMUSG00000050556, Kcnb1, potassium voltage gated channel, Shab-related subfamily, member 1, [Score=209, Expect=2e-57]; ENSMUSG00000092083, Kcnb2, potassium voltage gated channel, Shab-related subfamily, member 2, [Score=206, Expect=2e-56]; ENSMUSG00000027895, Kcnc4, potassium voltage gated channel, Shaw-related subfamily, member 4, [Score=204, Expect=4e-57]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=203, Expect=1e-56]; ENSMUSG00000062785, Kcnc3, potassium voltage gated channel, Shaw-related subfamily, member 3, [Score=203, Expect=4e-56]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=223, Expect=2e-65]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=224, Expect=8e-65]} {Smed: dd_Smed_v6_20858_0_1, dd_Smed_v6_20858_0_1, [RH, Score=567, Expect=0.0]} {RNA1509_22940} {RNA1310_28483} {RNA815_31040} |
46. | MligTC455_43959 | 93 | 1.94 | Mlig455_020049, Mlig455_022295 | Neo: - Age: Down-Up-Up |
1.68 | - | - | - | 0.708 | 0.972 | - | Mlig455_020049 {REF} {Length: 1131} {RNA1509_47842} {RNA1310_6450.2} {RNA815_45397} Mlig455_022295 {REF} {Length: 1494} {RNA1509_47842} {RNA1310_6450.2} {RNA815_45397} |
|
47. | MligTC455_31464 | 20 | 0.41 | Mlig455_057157 | Neo: - Age: - |
1.672 | - | - | 0.709 | - | 0.963 | - | Mlig455_057157 {REF} {Length: 1285} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=38.2]} {Smed: dd_Smed_v6_13824_0_1, dd_Smed_v6_13824_0_1, [RH, Score=47.0, Expect=2e-07]} {RNA1509_6604} {RNA1310_12860.1} {RNA815_6128.1} | |
48. | MligTC455_51557 | 57 | 1.19 | Mlig455_038195 | Neo: - Age: Down-Up-Up |
ISL1 | 1.67 | - | - | - | 0.701 | 0.969 | - | Mlig455_038195 {REF} {Length: 2149} {Pfam: LIM domain [PF00412.24, score=91.4]; Homeodomain [PF00046.31, score=55.3]; Homeobox KN domain [PF05920.13, score=23.4]} {Human: ENSG00000016082, ISL1, ISL LIM homeobox 1, [Score=180, Expect=9e-52]; ENSG00000159556, ISL2, ISL LIM homeobox 2, [Score=173, Expect=3e-49]} {Mouse: ENSMUSG00000042258, Isl1, ISL1 transcription factor, LIM/homeodomain, [Score=180, Expect=6e-52]; ENSMUSG00000032318, Isl2, insulin related protein 2 (islet 2), [Score=175, Expect=4e-50]} {Dmel: FBgn0003896, tup, tailup, [Score=151, Expect=3e-40]} {Celegans: WBGene00002989, lim-7, CeLIM-7; LIM domain family, [Score=142, Expect=2e-37]} {Smed: dd_Smed_v6_8820_0_1, dd_Smed_v6_8820_0_1, [Score=303, Expect=1e-97]} {RNA1310_54855} {RNA815_46288} |
49. | MligTC455_35003 | 75 | 1.57 | Mlig455_049853, Mlig455_063819 | Neo: - Age: - |
NOTCH1 | 1.667 | - | - | - | 0.706 | 0.961 | - | Mlig455_049853 {REF} {Length: 882} {Pfam: EGF-like domain [PF00008.29, score=19.8]; EGF-like domain [PF07974.15, score=19.3]} {Human: ENSG00000148400, NOTCH1, notch 1, [Score=50.8, Expect=9e-08]; ENSG00000074181, NOTCH3, notch 3, [Score=49.3, Expect=4e-07]} {Mouse: ENSMUSG00000026923, Notch1, notch 1, [Score=48.5, Expect=5e-07]; ENSMUSG00000038146, Notch3, notch 3, [Score=47.4, Expect=9e-07]; ENSMUSG00000047793, Sned1, sushi, nidogen and EGF-like domains 1, [Score=47.0, Expect=2e-06]} {Dmel: FBgn0259140, CG42255, [Score=45.8, Expect=3e-06]} {Celegans: WBGene00000792, crb-1, Drosophila CRumBs homolog, [Score=48.5, Expect=3e-07]} {Smed: dd_Smed_v6_11876_0_1, dd_Smed_v6_11876_0_1, [Score=43.5, Expect=1e-05]} {RNA1509_48097} {RNA1310_33379} {RNA815_13326.2} Mlig455_063819 {REF} {Length: 1105} {Pfam: EGF-like domain [PF00008.29, score=21.2]} {Human: ENSG00000148400, NOTCH1, notch 1, [Score=52.0, Expect=1e-07]} {Mouse: ENSMUSG00000055333, Fat2, FAT atypical cadherin 2, [Score=50.4, Expect=3e-07]; ENSMUSG00000026923, Notch1, notch 1, [Score=48.9, Expect=1e-06]; ENSMUSG00000047793, Sned1, sushi, nidogen and EGF-like domains 1, [Score=48.1, Expect=2e-06]} {Dmel: FBgn0259140, CG42255, [Score=53.5, Expect=2e-08]} {Celegans: WBGene00000792, crb-1, Drosophila CRumBs homolog, [Score=50.4, Expect=2e-07]} {RNA1509_48097} {RNA1310_33379} {RNA815_13326.1} |
50. | MligTC455_43137 | 118 | 2.46 | Mlig455_043159 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.878 Region-enriched R2: 5.988/0.00166 |
1.665 | - | - | 0.703 | - | 0.962 | - | Mlig455_043159 {REF} {Length: 1651} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=25.7]} {RNA1509_48871} {RNA1310_23692, RNA1509_48871} {RNA1509_48871, RNA815_11317} | |
51. | MligTC455_17664 | 159 | 3.32 | Mlig455_006486, Mlig455_006606 | Neo: - |
PLCB1 | 1.659 | - | - | - | 0.704 | 0.955 | - | Mlig455_006486 {REF} {Length: 4855} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=200.4]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=125.9]; PH domain [PF17787.3, score=104.5]; Phosphoinositide-specific phospholipase C, efhand-like [PF09279.13, score=34.0]} {Human: ENSG00000182621, PLCB1, phospholipase C beta 1, [RH, Score=808, Expect=0.0]; ENSG00000149782, PLCB3, phospholipase C beta 3, [RH, Score=805, Expect=0.0]} {Mouse: ENSMUSG00000051177, Plcb1, phospholipase C, beta 1, [RH, Score=811, Expect=0.0]; ENSMUSG00000024960, Plcb3, phospholipase C, beta 3, [RH, Score=784, Expect=0.0]} {Dmel: FBgn0004611, Plc21C, Phospholipase C at 21C, [RH, Score=438, Expect=3e-131]} {Celegans: WBGene00001177, egl-8, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta egl-8, [Score=639, Expect=0.0]} {Smed: dd_Smed_v6_3221_0_1, dd_Smed_v6_3221_0_1, [Score=692, Expect=0.0]} {RNA1509_53425} {RNA1310_39849} {RNA815_30464} Mlig455_006606 {REF} {Length: 4322} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=199.3]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=126.1]; PH domain [PF17787.3, score=117.1]; Phosphoinositide-specific phospholipase C, efhand-like [PF09279.13, score=33.9]} {Human: ENSG00000182621, PLCB1, phospholipase C beta 1, [RH, Score=840, Expect=0.0]; ENSG00000149782, PLCB3, phospholipase C beta 3, [RH, Score=825, Expect=0.0]} {Mouse: ENSMUSG00000051177, Plcb1, phospholipase C, beta 1, [RH, Score=843, Expect=0.0]; ENSMUSG00000024960, Plcb3, phospholipase C, beta 3, [RH, Score=814, Expect=0.0]} {Dmel: FBgn0004611, Plc21C, Phospholipase C at 21C, [RH, Score=451, Expect=2e-136]} {Celegans: WBGene00001177, egl-8, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta egl-8, [Score=663, Expect=0.0]} {Smed: dd_Smed_v6_3221_0_2, dd_Smed_v6_3221_0_2, [Score=701, Expect=0.0]} {RNA1509_53425} {RNA1310_39849, RNA1509_53425} {RNA1509_53425, RNA815_30464} |
52. | MligTC455_05600 | 16 | 0.34 | Mlig455_063188 | Neo: - Age: - |
0.985 | - | - | - | - | 0.985 | - | Mlig455_063188 {REF} {Length: 1163} {NoTransDecoderORF} {RNA1310_54187} | |
53. | MligTC455_19694 | 101 | 2.1 | Mlig455_019126 | Neo: - Age: - |
HMCN1 | 0.985 | - | - | - | - | 0.985 | - | Mlig455_019126 {REF} {Length: 1904} {Pfam: Immunoglobulin domain [PF13927.8, score=96.3]; Immunoglobulin I-set domain [PF07679.18, score=82.1]; Immunoglobulin V-set domain [PF07686.19, score=63.8]; Immunoglobulin domain [PF00047.27, score=57.8]; Immunoglobulin domain [PF13895.8, score=55.6]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=88.6, Expect=8e-18]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=92.0, Expect=5e-19]; ENSMUSG00000055632, Hmcn2, hemicentin 2, [Score=88.6, Expect=6e-18]} {Dmel: FBgn0000071, Ama, Amalgam, [RH, Score=111, Expect=7e-27]} {Celegans: WBGene00004372, rig-5, NeuRonal IGCAM, [RH, Score=98.2, Expect=6e-22]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=64.3, Expect=1e-10]} {RNA1310_49122} {RNA815_40619} |
54. | MligTC455_50162 | 73 | 1.53 | Mlig455_042074 | Neo: - |
TLR2 | 0.984 | - | - | - | - | 0.984 | - | Mlig455_042074 {REF} {Length: 2789} {Pfam: Leucine rich repeat [PF13855.8, score=68.4]; Leucine Rich repeats (2 copies) [PF12799.9, score=27.4]} {Human: ENSG00000137462, TLR2, toll like receptor 2, [Score=52.0, Expect=5e-07]} {Dmel: FBgn0028888, CG4168, [Score=48.5, Expect=9e-06]} {RNA1310_9861.1} {RNA815_5552} |
55. | MligTC455_17298 | 50 | 1.04 | Mlig455_058995 | Neo: - Age: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_058995 {REF} {Length: 1306} {RNA1509_52268} {RNA1310_39317.2} {RNA815_42253} | |
56. | MligTC455_49372 | 354 | 7.38 | Mlig455_000027, Mlig455_063730 | Neo: - Age: Up-Down-Up |
ECT2 | 0.978 | - | - | - | - | 0.978 | - | Mlig455_000027 {REF} {Length: 2943} {Pfam: RhoGEF domain [PF00621.22, score=121.5]} {Human: ENSG00000114346, ECT2, epithelial cell transforming 2, [Score=71.6, Expect=3e-12]} {Mouse: ENSMUSG00000027699, Ect2, ect2 oncogene, [Score=70.1, Expect=5e-12]; ENSMUSG00000023800, Tiam2, T cell lymphoma invasion and metastasis 2, [Score=68.9, Expect=2e-11]} {Dmel: FBgn0262562, CG43102, [Score=81.3, Expect=2e-15]} {Celegans: WBGene00002297, ect-2, ECT2 (Mammalian Rho GEF) homolog, [Score=60.1, Expect=4e-09]} {Smed: dd_Smed_v6_2922_0_1, dd_Smed_v6_2922_0_1, [Score=59.3, Expect=6e-09]} {RNA1509_60002} {RNA1310_20096} {RNA815_13312} Mlig455_063730 {REF} {Length: 4407} {Pfam: RhoGEF domain [PF00621.22, score=122.0]} {Human: ENSG00000114346, ECT2, epithelial cell transforming 2, [Score=71.2, Expect=4e-12]} {Mouse: ENSMUSG00000027699, Ect2, ect2 oncogene, [Score=70.1, Expect=5e-12]; ENSMUSG00000023800, Tiam2, T cell lymphoma invasion and metastasis 2, [Score=68.6, Expect=2e-11]} {Dmel: FBgn0262562, CG43102, [Score=82.4, Expect=6e-16]} {Celegans: WBGene00002297, ect-2, ECT2 (Mammalian Rho GEF) homolog, [Score=60.5, Expect=2e-09]} {Smed: dd_Smed_v6_2922_0_1, dd_Smed_v6_2922_0_1, [Score=58.9, Expect=7e-09]} {RNA1509_60002} {RNA1310_20096} {RNA815_13312} |
57. | MligTC455_02855 | 144 | 3 | Mlig455_000237 | Neo: - Age: - |
B3GALT2 | 0.975 | - | - | - | - | 0.975 | - | Mlig455_000237 {REF} {Length: 757} {Pfam: Galactosyltransferase [PF01762.23, score=48.0]} {Human: ENSG00000162630, B3GALT2, beta-1,3-galactosyltransferase 2, [Score=48.5, Expect=8e-07]} {Mouse: ENSMUSG00000033849, B3galt2, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2, [Score=48.5, Expect=6e-07]} {Dmel: FBgn0035558, CG11357, [Score=61.6, Expect=1e-11]} {Smed: dd_Smed_v6_4748_0_1, dd_Smed_v6_4748_0_1, [Score=88.2, Expect=2e-21]} {RNA1509_17403} {RNA1310_48383} {RNA815_28728} |
58. | MligTC455_09509 | 46 | 0.95 | Mlig455_042043 | Neo: - Age: - |
0.975 | - | - | - | - | 0.975 | - | Mlig455_042043 {REF} {Length: 1543} {Pfam: SICA C-terminal inner membrane domain [PF12879.9, score=63.2]} {RNA1509_50446} {RNA1310_8738.1} {RNA815_21682.1} | |
59. | MligTC455_50164 | 30 | 0.62 | Mlig455_042298 | Neo: - Age: - |
LRRC70 | 0.975 | - | - | - | - | 0.975 | - | Mlig455_042298 {REF} {Length: 2101} {Pfam: Leucine rich repeat [PF13855.8, score=55.0]; Leucine Rich repeats (2 copies) [PF12799.9, score=27.6]; BspA type Leucine rich repeat region (6 copies) [PF13306.8, score=19.2]} {Human: ENSG00000186105, LRRC70, leucine rich repeat containing 70, [Score=50.1, Expect=7e-06]; ENSG00000137462, TLR2, toll like receptor 2, [Score=48.9, Expect=5e-06]} {Mouse: ENSMUSG00000046070, Igfals, insulin-like growth factor binding protein, acid labile subunit, [Score=50.1, Expect=4e-06]} {Dmel: FBgn0031100, CG1504, [Score=49.3, Expect=5e-06]} {RNA1310_10677} {RNA815_5552} |
60. | MligTC455_11789 | 8 | 0.17 | Mlig455_038453 | Neo: - Age: - |
0.974 | - | - | - | - | 0.974 | - | Mlig455_038453 {REF} {Length: 607} {NoTransDecoderORF} {RNA1509_18406} {RNA1310_72809} | |
61. | MligTC455_18143 | 64 | 1.33 | Mlig455_052444 | Neo: - Age: - |
0.971 | - | - | - | - | 0.971 | - | Mlig455_052444 {REF} {Length: 3418} {NoTransDecoderORF} {RNA1509_7715} {RNA1310_17276.1} {RNA815_2054.2} | |
62. | MligTC455_53467 | 98 | 2.05 | Mlig455_032611 | Neo: - Age: Down-Down-Up Region-enriched R8: 4.858/0.00151 |
0.971 | - | - | - | - | 0.971 | - | Mlig455_032611 {REF} {Length: 2547} {Pfam: Carbohydrate binding domain (family 19) [PF03427.15, score=19.0]} {RNA1509_1990} {RNA1310_48790} {RNA815_9320.1} | |
63. | MligTC455_42391 | 1050 | 21.88 | Mlig455_010516, Mlig455_061820, Mlig455_061856, Mlig455_061864 | Neo: - Age: Down-Up-Up |
0.968 | - | - | - | - | 0.968 | - | Mlig455_010516 {REF} {Length: 729} {RNA1509_38791} {RNA1310_69853, RNA1509_38791} {RNA1509_38791, RNA815_39199} Mlig455_061820 {REF} {Length: 705} {RNA1509_38791} {RNA1310_69853} {RNA815_39199} Mlig455_061856 {REF} {Length: 708} {RNA1509_38791} {RNA1310_69853} {RNA815_39199} Mlig455_061864 {REF} {Length: 1146} {RNA1509_38791} {RNA1310_69853} {RNA815_39199} |
|
64. | MligTC455_41512 | 268 | 5.59 | Mlig455_057018 | Neo: - Age: Down-Down-Up |
HMCN2 | 0.966 | - | - | - | - | 0.966 | - | Mlig455_057018 {REF} {Length: 2115} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=167.2]; Immunoglobulin domain [PF13927.8, score=124.8]; Immunoglobulin domain [PF13895.8, score=78.7]; Immunoglobulin domain [PF00047.27, score=77.2]; Immunoglobulin V-set domain [PF07686.19, score=45.1]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=40.4]} {Human: ENSG00000148357, HMCN2, hemicentin 2, [Score=83.6, Expect=3e-16]; ENSG00000138347, MYPN, myopalladin, [Score=82.8, Expect=4e-16]; ENSG00000129116, PALLD, palladin, cytoskeletal associated protein, [Score=82.4, Expect=4e-16]; ENSG00000072195, SPEG, SPEG complex locus, [Score=82.0, Expect=6e-16]} {Mouse: ENSMUSG00000061462, Obscn, obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF, [Score=84.7, Expect=8e-17]; ENSMUSG00000058056, Palld, palladin, cytoskeletal associated protein, [Score=81.6, Expect=4e-16]; ENSMUSG00000026207, Speg, SPEG complex locus, [Score=80.9, Expect=9e-16]} {Dmel: FBgn0052311, zormin, [Score=102, Expect=7e-23]} {Celegans: WBGene00006820, unc-89, Muscle M-line assembly protein unc-89, [Score=77.4, Expect=8e-15]} {Smed: dd_Smed_v6_13910_0_1, dd_Smed_v6_13910_0_1, [Score=127, Expect=3e-31]} {RNA1509_44395} {RNA1310_15128.1, RNA1509_44395} {RNA1509_44395, RNA815_29263} |
65. | MligTC455_06838 | 42 | 0.88 | Mlig455_063567 | Neo: - Age: Down-Down-Up |
0.965 | - | - | - | - | 0.965 | - | Mlig455_063567 {REF} {Length: 1509} {RNA1310_26608} | |
66. | MligTC455_16841 | 31 | 0.65 | Mlig455_020666 | Neo: - Age: - Region-enriched R5: 2.930/0.04908 |
0.965 | - | - | - | - | - | 0.965 | Mlig455_020666 {REF} {Length: 867} {NoTransDecoderORF} {RNA1310_46795} {RNA815_57807} | |
67. | MligTC455_17895 | 389 | 8.1 | Mlig455_060774 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.268 Region-specific R2: 7.424 Region-enriched R2: 6.488/0.00062 Regeneration-downregulated R2: -4.133 Regeneration-depleted R2: -4.133 |
0.965 | - | - | - | - | 0.965 | - | Mlig455_060774 {REF} {Length: 1670} {RNA1509_34403} {RNA1310_35901, RNA1509_34403} {RNA1509_34403, RNA815_35590} | |
68. | MligTC455_53720 | 144 | 2.99 | Mlig455_028516 | Neo: - Age: - Region-enriched R2: 4.205/0.01762 |
CTBP2 | 0.965 | - | - | - | - | 0.965 | - | Mlig455_028516 {REF} {Length: 3357} {TRANSSPLICED} {Pfam: D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain [PF02826.21, score=112.7]; D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain [PF00389.32, score=67.2]; THAP domain [PF05485.14, score=38.8]; NAD binding domain of 6-phosphogluconate dehydrogenase [PF03446.17, score=22.2]} {Human: ENSG00000175029, CTBP2, C-terminal binding protein 2, [Score=370, Expect=3e-115]; ENSG00000159692, CTBP1, C-terminal binding protein 1, [Score=360, Expect=1e-117]} {Mouse: ENSMUSG00000030970, Ctbp2, C-terminal binding protein 2, [Score=372, Expect=5e-116]; ENSMUSG00000037373, Ctbp1, C-terminal binding protein 1, [Score=362, Expect=8e-119]} {Dmel: FBgn0020496, CtBP, C-terminal Binding Protein, [Score=354, Expect=1e-116]} {Celegans: WBGene00006424, ctbp-1, C-terminal-binding protein 1, [Score=475, Expect=8e-159]} {Smed: dd_Smed_v6_1063_0_1, dd_Smed_v6_1063_0_1, [Score=354, Expect=3e-115]} {RNA1310_37204} {RNA815_48484} |
69. | MligTC455_18607 | 203 | 4.23 | Mlig455_012344, Mlig455_012722 | Neo: - Age: - Region-enriched R2: 3.338/0.02204 |
ANKRD63 | 0.964 | - | - | - | - | 0.964 | - | Mlig455_012344 {REF} {Length: 1989} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=77.3]; Ankyrin repeats (many copies) [PF13637.8, score=67.3]; Ankyrin repeat [PF00023.32, score=56.6]; Ankyrin repeats (many copies) [PF13857.8, score=50.3]; Ankyrin repeat [PF13606.8, score=47.6]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=55.5, Expect=5e-08]} {Celegans: WBGene00006882, vab-19, VAB-19, [Score=52.0, Expect=5e-07]} {Smed: dd_Smed_v6_11187_0_1, dd_Smed_v6_11187_0_1, [Score=59.3, Expect=2e-09]} {RNA1310_37830} {RNA815_38436} Mlig455_012722 {REF} {Length: 2256} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=77.2]; Ankyrin repeats (many copies) [PF13637.8, score=67.3]; Ankyrin repeat [PF00023.32, score=56.6]; Ankyrin repeats (many copies) [PF13857.8, score=50.3]; Ankyrin repeat [PF13606.8, score=47.6]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Dmel: FBgn0031473, CG3104, [Score=54.7, Expect=5e-08]} {Celegans: WBGene00006882, vab-19, VAB-19, [Score=52.0, Expect=5e-07]} {Smed: dd_Smed_v6_11187_0_2, dd_Smed_v6_11187_0_2, [Score=59.7, Expect=1e-09]} {RNA1310_37830} {RNA815_38436} |
70. | MligTC455_36990 | 44 | 0.91 | Mlig455_042274 | Neo: - Age: - |
0.964 | - | - | - | - | 0.964 | - | Mlig455_042274 {REF} {Length: 1793} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=36.0]; TgpA N-terminal domain [PF11992.10, score=19.0]} {Smed: dd_Smed_v6_24483_0_1, dd_Smed_v6_24483_0_1, [RH, Score=138, Expect=2e-36]} {RNA1310_21197} {RNA815_30263} | |
71. | MligTC455_39991 | 66 | 1.38 | Mlig455_021997 | Neo: - Age: - |
GLRA2 | 0.963 | - | - | - | - | 0.963 | - | Mlig455_021997 {REF} {Length: 3430} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=119.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=74.5]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=210, Expect=4e-62]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=208, Expect=3e-61]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=207, Expect=6e-61]; ENSG00000188828, GLRA4, glycine receptor alpha 4, [Score=202, Expect=2e-59]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=213, Expect=5e-63]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=207, Expect=7e-61]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=206, Expect=9e-61]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=203, Expect=1e-59]} {Dmel: FBgn0024963, GluClalpha, [Score=202, Expect=3e-59]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [Score=196, Expect=7e-57]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [Score=195, Expect=5e-57]} {RNA1310_40572} |
72. | MligTC455_37563 | 45 | 0.94 | Mlig455_025592, Mlig455_057216, Mlig455_060662 | Neo: - Age: Up-Down-Up |
GALR2, OPN4, TRHR | 0.962 | - | - | - | - | 0.962 | - | Mlig455_025592 {REF} {Length: 4246} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=86.7]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=77.2]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=58.5, Expect=8e-09]; ENSG00000174417, TRHR, thyrotropin releasing hormone receptor, [Score=57.8, Expect=1e-08]} {Mouse: ENSMUSG00000026237, Nmur1, neuromedin U receptor 1, [Score=57.8, Expect=9e-09]; ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=55.8, Expect=3e-08]} {Dmel: FBgn0038874, ETHR, [Score=86.7, Expect=3e-18]} {Celegans: WBGene00020586, frpr-18, FLP-2 receptor; FMRFamide Peptide Receptor family, [Score=93.6, Expect=1e-20]} {Smed: dd_Smed_v6_16149_0_1, dd_Smed_v6_16149_0_1, [RH, Score=164, Expect=2e-47]} {RNA1509_10419} {RNA1310_74041} {RNA815_44148} Mlig455_057216 {REF} {Length: 2773} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=87.0]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=77.5]} {Human: ENSG00000174417, TRHR, thyrotropin releasing hormone receptor, [Score=57.0, Expect=2e-08]; ENSG00000182687, GALR2, galanin receptor 2, [Score=55.5, Expect=6e-08]} {Mouse: ENSMUSG00000026237, Nmur1, neuromedin U receptor 1, [Score=57.8, Expect=7e-09]} {Dmel: FBgn0038874, ETHR, [Score=86.3, Expect=3e-18]} {Celegans: WBGene00020586, frpr-18, FLP-2 receptor; FMRFamide Peptide Receptor family, [Score=92.0, Expect=2e-20]} {Smed: dd_Smed_v6_16149_0_1, dd_Smed_v6_16149_0_1, [RH, Score=162, Expect=7e-47]} {RNA1509_50426} {RNA1310_74041} {RNA815_44148} Mlig455_060662 {REF} {Length: 1185} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=76.7]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=67.1]} {Human: ENSG00000122375, OPN4, opsin 4, [Score=50.4, Expect=3e-06]; ENSG00000174417, TRHR, thyrotropin releasing hormone receptor, [Score=48.9, Expect=7e-06]} {Dmel: FBgn0029723, Proc-R, Proctolin receptor, [Score=73.9, Expect=4e-14]} {Celegans: WBGene00020586, frpr-18, FLP-2 receptor; FMRFamide Peptide Receptor family, [Score=77.0, Expect=3e-15]} {Smed: dd_Smed_v6_16149_0_1, dd_Smed_v6_16149_0_1, [Score=144, Expect=6e-40]} {RNA1310_74041} {RNA815_42171} |
73. | MligTC455_49373 | 49 | 1.03 | Mlig455_000061 | Neo: - Age: - |
ECT2 | 0.962 | - | - | - | - | 0.962 | - | Mlig455_000061 {REF} {Length: 2785} {Pfam: RhoGEF domain [PF00621.22, score=121.5]; ZIP Zinc transporter [PF02535.24, score=20.6]} {Human: ENSG00000114346, ECT2, epithelial cell transforming 2, [Score=72.8, Expect=2e-13]} {Mouse: ENSMUSG00000027699, Ect2, ect2 oncogene, [Score=72.8, Expect=1e-13]} {Dmel: FBgn0262562, CG43102, [Score=77.4, Expect=3e-15]} {Celegans: WBGene00002297, ect-2, ECT2 (Mammalian Rho GEF) homolog, [Score=58.9, Expect=2e-09]} {Smed: dd_Smed_v6_2922_0_1, dd_Smed_v6_2922_0_1, [Score=52.8, Expect=2e-07]} {RNA1509_60002} {RNA1310_20791, RNA1509_60002} {RNA1509_60002, RNA815_13312} |
74. | MligTC455_38175 | 39 | 0.81 | Mlig455_041332, Mlig455_056218 | Neo: - Age: - |
DNAH9 | 0.961 | - | - | - | - | 0.961 | - | Mlig455_041332 {REF} {Length: 11655} {Pfam: Dynein heavy chain, N-terminal region 1 [PF08385.14, score=560.7]; Hydrolytic ATP binding site of dynein motor region [PF12774.9, score=503.4]; Dynein heavy chain, N-terminal region 2 [PF08393.15, score=327.1]; AAA domain (dynein-related subfamily) [PF07728.16, score=68.8]; AAA domain [PF13401.8, score=24.4]; P-loop containing dynein motor region [PF12775.9, score=21.7]; AAA domain [PF13238.8, score=21.3]; AAA ATPase domain [PF13191.8, score=19.6]} {Human: ENSG00000007174, DNAH9, dynein axonemal heavy chain 9, [Score=2544, Expect=0.0]; ENSG00000187775, DNAH17, dynein axonemal heavy chain 17, [Score=2525, Expect=0.0]} {Mouse: ENSMUSG00000056752, Dnah9, dynein, axonemal, heavy chain 9, [Score=2547, Expect=0.0]; ENSMUSG00000033987, Dnah17, dynein, axonemal, heavy chain 17, [Score=2516, Expect=0.0]} {Dmel: FBgn0013812, Dhc93AB, Dynein heavy chain at 93AB, [Score=2306, Expect=0.0]} {Celegans: WBGene00000962, dhc-1, Dynein heavy chain, cytoplasmic, [Score=573, Expect=8e-167]} {Smed: dd_Smed_v6_3670_0_1, dd_Smed_v6_3670_0_1, [Score=2819, Expect=0.0]} {RNA1509_7397} {RNA1310_128.1} {RNA815_30.1} Mlig455_056218 {REF} {Length: 12040} {Pfam: Hydrolytic ATP binding site of dynein motor region [PF12774.9, score=505.5]; Dynein heavy chain, N-terminal region 2 [PF08393.15, score=433.1]; P-loop containing dynein motor region [PF12775.9, score=256.0]; Dynein heavy chain AAA lid domain [PF17852.3, score=97.3]; AAA domain (dynein-related subfamily) [PF07728.16, score=87.1]; AAA domain [PF13401.8, score=29.7]; AAA ATPase domain [PF13191.8, score=29.6]; AAA domain [PF13604.8, score=25.4]; AAA domain [PF13245.8, score=25.3]; Sigma-54 interaction domain [PF00158.28, score=22.2]; ATPase family associated with various cellular activities (AAA) [PF00004.31, score=21.7]; AAA domain [PF13238.8, score=20.7]; Sigma-54 interaction domain [PF14532.8, score=19.9]} {Human: ENSG00000007174, DNAH9, dynein axonemal heavy chain 9, [Score=2583, Expect=0.0]; ENSG00000187775, DNAH17, dynein axonemal heavy chain 17, [Score=2573, Expect=0.0]} {Mouse: ENSMUSG00000033987, Dnah17, dynein, axonemal, heavy chain 17, [Score=2600, Expect=0.0]; ENSMUSG00000056752, Dnah9, dynein, axonemal, heavy chain 9, [Score=2590, Expect=0.0]} {Dmel: FBgn0013812, Dhc93AB, Dynein heavy chain at 93AB, [Score=2405, Expect=0.0]} {Celegans: WBGene00000962, dhc-1, Dynein heavy chain, cytoplasmic, [Score=632, Expect=0.0]} {Smed: dd_Smed_v6_3670_0_1, dd_Smed_v6_3670_0_1, [Score=2818, Expect=0.0]} {RNA1509_140, RNA1509_15019} {RNA1310_737, RNA1509_15019} {RNA1509_15019, RNA815_30.1} |
75. | MligTC455_26102 | 81 | 1.68 | Mlig455_036981 | Neo: Irradiation Age: logFC(26M/2M)=-0.711 |
0.96 | - | - | - | - | 0.960 | - | Mlig455_036981 {REF} {Length: 2593} {RNA1509_51525} {RNA1310_9237.1} {RNA815_5309} | |
76. | MligTC455_11254 | 19 | 0.4 | Mlig455_060079 | Neo: - Age: - |
0.959 | - | - | - | - | 0.959 | - | Mlig455_060079 {REF} {Length: 1689} {Pfam: Glycine rich protein [PF12810.9, score=20.4]} | |
77. | MligTC455_11369 | 352 | 7.34 | Mlig455_020293 | Neo: - Age: logFC(26M/2M)=-0.516 |
0.958 | - | - | - | - | 0.958 | - | Mlig455_020293 {REF} {Length: 1579} {Pfam: Rel homology DNA-binding domain [PF00554.24, score=40.7]} {RNA1509_26893} {RNA1310_2708} {RNA815_9370.1} | |
78. | MligTC455_13006 | 55 | 1.15 | Mlig455_044901 | Neo: - Age: - |
PCDH11Y | 0.957 | - | - | - | - | 0.957 | - | Mlig455_044901 {REF} {Length: 6092} {Pfam: Cadherin domain [PF00028.19, score=276.7]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=79.8]; Cadherin-like [PF08266.14, score=44.2]; Cadherin-like [PF16184.7, score=39.5]; Cadherin prodomain like [PF08758.13, score=30.3]} {Human: ENSG00000099715, PCDH11Y, protocadherin 11 Y-linked, [Score=292, Expect=5e-80]; ENSG00000102290, PCDH11X, protocadherin 11 X-linked, [Score=291, Expect=5e-80]} {Mouse: ENSMUSG00000034755, Pcdh11x, protocadherin 11 X-linked, [Score=281, Expect=9e-78]} {Dmel: FBgn0001075, ft, fat, [Score=239, Expect=3e-63]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=206, Expect=3e-53]} {Smed: dd_Smed_v6_18373_0_1, dd_Smed_v6_18373_0_1, [Score=290, Expect=1e-80]} {RNA1509_54067} {RNA1310_21501} {RNA815_32416} |
79. | MligTC455_13165 | 181 | 3.77 | Mlig455_018648 | Neo: - Age: - Region-specific R2: 6.131 Region-enriched R2: 4.463/0.01828 Regeneration-downregulated R2: -3.253 Regeneration-depleted R2: -3.253 |
0.957 | - | - | - | - | 0.957 | - | Mlig455_018648 {REF} {Length: 1920} {TRANSSPLICED} {Pfam: FAD dependent oxidoreductase [PF01266.26, score=209.8]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=21.6]; FAD binding domain [PF01494.21, score=20.4]; Pyridine nucleotide-disulphide oxidoreductase [PF07992.16, score=19.9]; FAD binding domain [PF00890.26, score=18.9]} {Mouse: ENSMUSG00000033624, Pdpr, pyruvate dehydrogenase phosphatase regulatory subunit, [Score=51.6, Expect=2e-06]} {Smed: dd_Smed_v6_5776_0_1, dd_Smed_v6_5776_0_1, [RH, Score=246, Expect=2e-77]} {RNA1509_25789} {RNA1310_15994} {RNA815_21830} | |
80. | MligTC455_48863 | 632 | 13.16 | Mlig455_069179 | Neo: - Age: Up-Down-Up |
TTN | 0.957 | - | - | - | - | 0.957 | - | Mlig455_069179 {REF} {Length: 3652} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=230.7]; Immunoglobulin domain [PF13927.8, score=130.9]; Immunoglobulin domain [PF00047.27, score=84.8]; Immunoglobulin domain [PF13895.8, score=83.5]; Immunoglobulin V-set domain [PF07686.19, score=40.2]; Immunoglobulin C1-set domain [PF07654.17, score=22.3]} {Human: ENSG00000155657, TTN, titin, [Score=105, Expect=3e-22]} {Mouse: ENSMUSG00000051747, Ttn, titin, [Score=105, Expect=2e-22]} {Dmel: FBgn0086906, sls, sallimus, [Score=338, Expect=1e-96]} {Celegans: WBGene00004130, ketn-1, KETtiN (Drosophila actin-binding) homolog; Kettin, [Score=276, Expect=2e-76]} {Smed: dd_Smed_v6_2928_0_1, dd_Smed_v6_2928_0_1, [RH, Score=540, Expect=4e-178]} {RNA1509_11032} {RNA1310_1392.2, RNA1509_11032} {RNA1509_11032, RNA815_689.1} |
81. | MligTC455_13166 | 186 | 3.88 | Mlig455_018849 | Neo: - Age: - Region-specific R2: 6.227 |
0.956 | - | - | - | - | 0.956 | - | Mlig455_018849 {REF} {Length: 693} {Pfam: FAD dependent oxidoreductase [PF01266.26, score=209.8]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=21.6]; FAD binding domain [PF01494.21, score=20.4]; Pyridine nucleotide-disulphide oxidoreductase [PF07992.16, score=19.9]; FAD binding domain [PF00890.26, score=18.9]} {Mouse: ENSMUSG00000033624, Pdpr, pyruvate dehydrogenase phosphatase regulatory subunit, [Score=51.6, Expect=2e-06]} {Smed: dd_Smed_v6_5776_0_1, dd_Smed_v6_5776_0_1, [RH, Score=246, Expect=2e-77]} {RNA1509_49819} {RNA1310_28647} {RNA815_1682.1} | |
82. | MligTC455_13948 | 28 | 0.59 | Mlig455_047707 | Neo: - Age: - |
CELSR2 | 0.956 | - | - | - | - | 0.956 | - | Mlig455_047707 {REF} {Length: 3244} {Pfam: Cadherin domain [PF00028.19, score=132.5]} {Human: ENSG00000143126, CELSR2, cadherin EGF LAG seven-pass G-type receptor 2, [Score=159, Expect=6e-39]; ENSG00000008300, CELSR3, cadherin EGF LAG seven-pass G-type receptor 3, [Score=154, Expect=3e-37]; ENSG00000196159, FAT4, FAT atypical cadherin 4, [Score=152, Expect=9e-37]} {Mouse: ENSMUSG00000016028, Celsr1, cadherin, EGF LAG seven-pass G-type receptor 1, [Score=163, Expect=3e-40]; ENSMUSG00000068740, Celsr2, cadherin, EGF LAG seven-pass G-type receptor 2, [Score=159, Expect=5e-39]} {Dmel: FBgn0038439, Cad89D, Cadherin 89D, [Score=167, Expect=6e-42]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=141, Expect=8e-34]} {Smed: dd_Smed_v6_15356_0_1, dd_Smed_v6_15356_0_1, [Score=115, Expect=5e-26]} {RNA1310_40769} {RNA815_46115} |
83. | MligTC455_40863 | 70 | 1.46 | Mlig455_014267 | Neo: - Age: Up-Down-Down |
PCDH1 | 0.956 | - | - | - | - | 0.956 | - | Mlig455_014267 {REF} {Length: 5379} {Pfam: Cadherin domain [PF00028.19, score=328.1]; Cadherin-like [PF16184.7, score=31.3]; Cadherin-like [PF08266.14, score=29.2]} {Human: ENSG00000156453, PCDH1, protocadherin 1, [RH, Score=298, Expect=2e-84]} {Mouse: ENSMUSG00000051375, Pcdh1, protocadherin 1, [RH, Score=300, Expect=3e-85]} {Dmel: FBgn0284247, ds, dachsous, [Score=269, Expect=2e-73]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=197, Expect=6e-51]} {Smed: dd_Smed_v6_14117_0_1, dd_Smed_v6_14117_0_1, [Score=404, Expect=8e-123]} {RNA1310_32856} {RNA815_39004} |
84. | MligTC455_08443 | 13 | 0.27 | Mlig455_068801 | Neo: Int S/G2/M Age: - |
0.955 | - | - | - | - | 0.955 | - | Mlig455_068801 {REF} {Length: 555} {RNA1509_49925} {RNA1310_1354} {RNA815_353.1} | |
85. | MligTC455_48713 | 380 | 7.92 | Mlig455_009259, Mlig455_009268 | Neo: - Age: Down-Up-Down Region-specific R2: 6.962 Region-enriched R2: 4.845/0.00046 |
0.955 | - | - | - | - | 0.955 | - | Mlig455_009259 {REF} {Length: 654} {RNA1509_35038} {RNA1310_72135} {RNA815_37404} Mlig455_009268 {REF} {Length: 546} {RNA1509_35038} {RNA1310_72135, RNA1509_35038} {RNA1509_35038, RNA815_37404} |
|
86. | MligTC455_53199 | 76 | 1.58 | Mlig455_035187 | Neo: - Age: Up-Down-Down |
0.955 | - | - | - | - | 0.955 | - | Mlig455_035187 {REF} {Length: 4248} {Pfam: MyTH4 domain [PF00784.19, score=60.4]} {Smed: dd_Smed_v6_19214_0_1, dd_Smed_v6_19214_0_1, [RH, Score=172, Expect=1e-46]} {RNA1310_70974} {RNA815_46536} | |
87. | MligTC455_53251 | 67 | 1.4 | Mlig455_018510 | Neo: - Age: logFC(26M/2M)=0.877 Region-enriched R2: 4.210/0.03685 |
SYT7 | 0.955 | - | - | - | - | 0.955 | - | Mlig455_018510 {REF} {Length: 3473} {Pfam: C2 domain [PF00168.32, score=157.9]} {Human: ENSG00000011347, SYT7, synaptotagmin 7, [RH, Score=261, Expect=1e-79]} {Mouse: ENSMUSG00000024743, Syt7, synaptotagmin VII, [RH, Score=251, Expect=2e-77]} {Dmel: FBgn0039900, Syt7, Synaptotagmin 7, [Score=233, Expect=6e-74]} {Celegans: WBGene00004923, snt-3, SyNapTotagmin, [Score=179, Expect=4e-53]} {Smed: dd_Smed_v6_4222_0_1, dd_Smed_v6_4222_0_1, [Score=194, Expect=1e-57]} {RNA1509_49257} {RNA1310_13701} {RNA815_8339} |
88. | MligTC455_16844 | 22 | 0.47 | Mlig455_032383 | Neo: - Age: - |
NPY1R | 0.954 | - | - | - | - | 0.954 | - | Mlig455_032383 {REF} {Length: 1642} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=126.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=23.7]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [Score=111, Expect=2e-26]} {Mouse: ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [Score=110, Expect=3e-26]; ENSMUSG00000048337, Npy4r, neuropeptide Y receptor Y4, [Score=108, Expect=1e-25]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=152, Expect=8e-41]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=135, Expect=4e-35]} {Smed: dd_Smed_v6_17752_0_1, dd_Smed_v6_17752_0_1, [Score=216, Expect=3e-65]} {RNA1310_56955} |
89. | MligTC455_36909 | 40 | 0.83 | Mlig455_031665 | Neo: - Age: - |
0.954 | - | - | - | - | 0.954 | - | Mlig455_031665 {REF} {Length: 992} {NoTransDecoderORF} {RNA1509_36080} {RNA1310_44068} {RNA815_39601} | |
90. | MligTC455_37371 | 44 | 0.92 | Mlig455_032355 | Neo: - Age: Down-Up-Down |
0.954 | - | - | - | - | 0.954 | - | Mlig455_032355 {REF} {Length: 2440} {RNA1310_9941.1} {RNA815_16538} | |
91. | MligTC455_49919 | 745 | 15.52 | Mlig455_017182, Mlig455_048150 | Neo: - Age: - Region-specific R2: 7.180 Region-enriched R2: 7.978/0.00000 Regeneration-downregulated R2: -4.649 Regeneration-depleted R2: -4.649 |
0.954 | - | - | - | - | 0.954 | - | Mlig455_017182 {REF} {Length: 576} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1310_60849, RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1509_35830, RNA1509_49816, RNA1509_53987, RNA815_31347} Mlig455_048150 {REF} {Length: 574} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830} {RNA1310_60849} {RNA815_31347} |
|
92. | MligTC455_15215 | 22 | 0.46 | Mlig455_037928 | Neo: - Age: - |
CHRNA9 | 0.953 | - | - | - | - | 0.953 | - | Mlig455_037928 {REF} {Length: 2079} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=180.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=57.1]} {Human: ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=221, Expect=7e-65]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=220, Expect=2e-64]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=220, Expect=2e-64]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=218, Expect=9e-64]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=216, Expect=2e-63]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=222, Expect=1e-65]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=219, Expect=3e-64]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=214, Expect=7e-63]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=228, Expect=2e-65]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=221, Expect=6e-65]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=214, Expect=1e-62]} {RNA1310_88831} |
93. | MligTC455_23047 | 66 | 1.36 | Mlig455_057970 | Neo: - Age: Up-Down-Down |
SGSM1 | 0.953 | - | - | - | - | 0.953 | - | Mlig455_057970 {REF} {Length: 4688} {Pfam: Rab-GTPase-TBC domain [PF00566.20, score=83.8]; RUN domain [PF02759.21, score=76.3]; Rab-binding domain (RBD) [PF12068.10, score=74.4]} {Human: ENSG00000167037, SGSM1, small G protein signaling modulator 1, [RH, Score=370, Expect=4e-109]} {Mouse: ENSMUSG00000042216, Sgsm1, small G protein signaling modulator 1, [RH, Score=367, Expect=4e-112]} {Dmel: FBgn0031116, CG1695, [Score=381, Expect=6e-113]} {Celegans: WBGene00008018, tbc-8, TBC (Tre-2/Bub2/Cdc16) domain family, [Score=219, Expect=1e-58]} {Smed: dd_Smed_v6_12130_0_1, dd_Smed_v6_12130_0_1, [Score=474, Expect=2e-148]} {RNA1310_35495.2} {RNA815_26008} |
94. | MligTC455_23142 | 769 | 16.02 | Mlig455_008044 | Neo: - Age: - |
INSR | 0.953 | - | - | - | - | 0.953 | - | Mlig455_008044 {REF} {Length: 5353} {TRANSSPLICED} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=291.8]; Protein kinase domain [PF00069.27, score=128.4]; Receptor L domain [PF01030.26, score=118.4]; Furin-like cysteine rich region [PF00757.22, score=79.0]; Fibronectin type III domain [PF00041.23, score=45.0]; Growth factor receptor domain IV [PF14843.8, score=19.9]} {Human: ENSG00000171105, INSR, insulin receptor, [RH, Score=647, Expect=0.0]} {Mouse: ENSMUSG00000005534, Insr, insulin receptor, [RH, Score=643, Expect=0.0]} {Dmel: FBgn0283499, InR, Insulin-like receptor, [RH, Score=333, Expect=8e-93]} {Celegans: WBGene00000898, daf-2, Insulin-like receptor Insulin-like receptor subunit alpha Insulin-like receptor subunit beta, [RH, Score=474, Expect=3e-140]} {Smed: dd_Smed_v6_9006_0_1, dd_Smed_v6_9006_0_1, [RH, Score=514, Expect=3e-157]} {RNA1509_5152} {RNA1310_762.1} {RNA815_285.1} |
95. | MligTC455_09457 | 18 | 0.37 | Mlig455_030003 | Neo: - Age: - |
0.952 | - | - | - | - | 0.952 | - | Mlig455_030003 {REF} {Length: 1601} {RNA1509_44134} {RNA1310_63608.1} {RNA815_45870} | |
96. | MligTC455_11785 | 333 | 6.93 | Mlig455_055379 | Neo: Germline Age: - |
NUCB2 | 0.952 | - | - | - | - | 0.952 | - | Mlig455_055379 {REF} {Length: 2224} {TRANSSPLICED} {Pfam: EF hand [PF00036.34, score=30.1]; EF-hand domain pair [PF13499.8, score=29.7]; EF-hand domain [PF13405.8, score=29.6]} {Human: ENSG00000070081, NUCB2, nucleobindin 2, [RH, Score=211, Expect=7e-64]; ENSG00000104805, NUCB1, nucleobindin 1, [RH, Score=211, Expect=1e-63]} {Mouse: ENSMUSG00000030824, Nucb1, nucleobindin 1, [RH, Score=219, Expect=9e-67]; ENSMUSG00000030659, Nucb2, nucleobindin 2, [RH, Score=209, Expect=3e-63]} {Dmel: FBgn0052190, NUCB1, [RH, Score=198, Expect=6e-58]} {Celegans: WBGene00009674, nucb-1, NUCleoBindin homolog, [RH, Score=172, Expect=3e-49]} {Smed: dd_Smed_v6_1728_0_1, dd_Smed_v6_1728_0_1, [RH, Score=263, Expect=1e-84]} {RNA1509_7514} {RNA1310_17099, RNA1509_7514} {RNA1509_7514, RNA815_6975} |
97. | MligTC455_17784 | 11 | 0.23 | Mlig455_001273 | Neo: - Age: - Region-enriched R4: 2.910/0.04306 |
GABBR1 | 0.951 | - | - | - | - | 0.951 | - | Mlig455_001273 {REF} {Length: 1909} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=119.7]; Receptor family ligand binding region [PF01094.30, score=29.4]} {Human: ENSG00000237112, GABBR1, gamma-aminobutyric acid type B receptor subunit 1, [Score=166, Expect=3e-43]; ENSG00000206466, GABBR1, gamma-aminobutyric acid type B receptor subunit 1, [Score=166, Expect=3e-43]; ENSG00000232569, GABBR1, gamma-aminobutyric acid type B receptor subunit 1, [Score=166, Expect=3e-43]; ENSG00000206511, GABBR1, gamma-aminobutyric acid type B receptor subunit 1, [Score=166, Expect=3e-43]; ENSG00000237051, GABBR1, gamma-aminobutyric acid type B receptor subunit 1, [Score=166, Expect=3e-43]; ENSG00000204681, GABBR1, gamma-aminobutyric acid type B receptor subunit 1, [Score=166, Expect=3e-43]; ENSG00000232632, GABBR1, gamma-aminobutyric acid type B receptor subunit 1, [Score=166, Expect=3e-43]; ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=164, Expect=2e-42]} {Mouse: ENSMUSG00000024462, Gabbr1, gamma-aminobutyric acid (GABA) B receptor, 1, [Score=166, Expect=1e-43]; ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=165, Expect=5e-43]} {Dmel: FBgn0260446, GABA-B-R1, metabotropic GABA-B receptor subtype 1, [Score=175, Expect=1e-46]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=159, Expect=2e-41]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=97.1, Expect=2e-22]} {RNA1509_32781} {RNA1310_75354} {RNA815_28313} |
98. | MligTC455_19850 | 21 | 0.44 | Mlig455_016817 | Neo: - |
GUCY1B1 | 0.951 | - | - | - | - | 0.951 | - | Mlig455_016817 {REF} {Length: 2782} {Pfam: Heme NO binding associated [PF07701.16, score=218.0]; Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=199.9]; Haem-NO-binding [PF07700.17, score=175.1]} {Human: ENSG00000061918, GUCY1B1, guanylate cyclase 1 soluble subunit beta 1, [Score=338, Expect=4e-107]} {Mouse: ENSMUSG00000028005, Gucy1b1, guanylate cyclase 1, soluble, beta 1, [Score=342, Expect=6e-109]; ENSMUSG00000021933, Gucy1b2, guanylate cyclase 1, soluble, beta 2, [Score=339, Expect=1e-105]} {Dmel: FBgn0038295, Gyc88E, Guanylyl cyclase at 88E, [RH, Score=593, Expect=0.0]} {Celegans: WBGene00001551, gcy-31, Soluble guanylate cyclase gcy-31, [RH, Score=513, Expect=2e-174]} {Smed: dd_Smed_v6_18111_0_1, dd_Smed_v6_18111_0_1, [RH, Score=823, Expect=0.0]} {RNA1509_55074} {RNA1310_24262} {RNA815_41754} |
99. | MligTC455_32501 | 34 | 0.71 | Mlig455_053552 | Neo: - Age: - Region-enriched R2: 9.313/0.01306 |
GRIA1 | 0.951 | - | - | - | - | 0.951 | - | Mlig455_053552 {REF} {Length: 4329} {Pfam: Ligand-gated ion channel [PF00060.28, score=197.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=125.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=87.5]; Receptor family ligand binding region [PF01094.30, score=76.3]} {Human: ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [RH, Score=605, Expect=0.0]; ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [RH, Score=577, Expect=0.0]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [RH, Score=577, Expect=0.0]} {Mouse: ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [RH, Score=603, Expect=0.0]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [RH, Score=582, Expect=0.0]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [RH, Score=576, Expect=0.0]} {Dmel: FBgn0004619, GluRIA, Glutamate receptor IA, [RH, Score=499, Expect=6e-161]} {Celegans: WBGene00001612, glr-1, Glutamate receptor 1, [RH, Score=504, Expect=2e-163]} {Smed: dd_Smed_v6_7562_0_1, dd_Smed_v6_7562_0_1, [RH, Score=740, Expect=0.0]} {RNA1509_47919} {RNA1310_3776} {RNA815_11355.1} |
100. | MligTC455_07053 | 23 | 0.47 | Mlig455_013671 | Neo: - Age: - |
0.95 | - | - | - | - | 0.950 | - | Mlig455_013671 {REF} {Length: 343} {RNA1509_19561} {RNA1310_8953} {RNA815_356.1} |